RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference

Rhea-AI Summary

RxSight (NASDAQ:RXST) announced that its management will present at the J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026 at 3:45 p.m. PT / 6:45 p.m. ET.

Investors and interested parties can access a live and archived webcast of the presentation at https://investors.rxsight.com/. No financial results or guidance were included in the announcement.

Key Figures

Conference date January 13, 2026 Scheduled J.P. Morgan Healthcare Conference presentation

Presentation time PT 3:45 p.m. PT Scheduled presentation time at conference

Presentation time ET 6:45 p.m. ET Corresponding Eastern Time for presentation

Market Reality Check

$10.38 Last Close

Volume Volume 814,218 is slightly above 20-day average 771,254 (relative 1.06x). normal

Technical Price $10.42 is trading below 200-day MA of $11.94, reflecting prior weakness.

Peers on Argus

RXST fell 3.43% while peers showed mixed, mostly modest moves: DCTH -0.49%, BFLY -1.3%, NPCE -0.06%, with CBLL +0.6% and SENS +0.36%, suggesting a stock-specific move rather than a sector-wide reaction.

Historical Context

Date	Event	Sentiment	Move	Catalyst
Dec 22	CFO transition	Neutral	+1.7%	CFO transition with consulting support and stable outlook message.
Nov 20	Conference appearance	Neutral	-5.8%	Piper Sandler healthcare conference presentation announcement.
Nov 05	Q3 2025 earnings	Negative	-7.3%	Lower Q3 revenue, wider loss, but strong margins and updated guidance.
Oct 22	Earnings date notice	Neutral	-1.2%	Announcement of Q3 results release date and investor call details.
Oct 16	Medical meeting events	Positive	-2.8%	Live learning sessions showcasing Light Adjustable Lens at AAO 2025.

Pattern Detected

Recent news often saw negative price reactions, especially around earnings and event announcements, with only one clearly aligned move on weaker financial results.

Recent Company History

Over the last few months, RxSight issued several operational and investor-relations updates. These included a CFO transition effective by Jan 31, 2026, multiple conference and meeting presentations, and detailed Q3 2025 financial results with lower sales but strong gross margins and narrowed full-year guidance. Most of these communications, even neutral conference announcements, were followed by share price declines, while the negative Q3 earnings news on Nov 5, 2025 also saw a notable drop. Today’s conference appearance update fits this pattern of frequent investor-facing events.

Market Pulse Summary

This announcement highlights RxSight’s participation in a major healthcare investor conference on January 13, 2026, providing management a platform to communicate its story and recent financial and operational trends. In prior months, the company reported softer quarterly sales with a wider loss but strong gross margins, and announced a CFO transition. Investors may watch for any updated commentary on growth, profitability, and execution during the conference webcast.

Key Terms

ophthalmic medical

"RxSight, Inc., an ophthalmic medical device company dedicated to providing..."

Relating to the eye and its care, including medicines, drops, diagnostic tools and surgical devices used to prevent, diagnose or treat eye conditions. Investors care because ophthalmic products form a distinct market with specialized safety approvals, manufacturing needs and payer coverage, so success or failure in this area can drive steady revenue or costly setbacks—think of it as a niche, high‑safety consumer product line for vision health.

cataract surgery medical

"customized vision to patients following cataract surgery, today announced plans..."

A surgical procedure that removes a cloudy natural lens in the eye and usually replaces it with a clear artificial lens, restoring vision much like cleaning or replacing a fogged camera lens to get a sharp picture again. It matters to investors because the procedure drives demand for medical devices, implants, surgical equipment and related services, so changes in procedure volume, technology, pricing or reimbursement can directly affect revenue and growth prospects for healthcare companies.

webcast technical

"Interested parties may access a live and archived webcast of the presentation..."

A webcast is a live or recorded online event where people watch or listen to presentations, announcements, or performances through the internet. It’s like a TV broadcast but over the internet, allowing viewers from anywhere to tune in in real time or later. Webcasts are important because they let companies share information quickly and widely with audiences around the world.

AI-generated analysis. Not financial advice.

ALISO VIEJO, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming J.P. Morgan Healthcare Conference.

RxSight’s management is scheduled to present on Tuesday, January 13, 2026, at 3:45 p.m. Pacific Time / 6:45 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation at: https://investors.rxsight.com/.

About RxSight, Inc.

RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL®/LAL+®, collectively the “LAL”), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.

Company Contact:
Shelley B. Thunen
Chief Financial Officer
sthunen@rxsight.com

Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
omoravcevic@rxsight.com

FAQ

When will RxSight (RXST) present at the J.P. Morgan Healthcare Conference?

RxSight management will present on January 13, 2026 at 3:45 p.m. PT / 6:45 p.m. ET.

How can investors watch the RxSight (RXST) presentation at the JP Morgan conference?

Investors can access a live and archived webcast at https://investors.rxsight.com/.

What topics will RxSight (RXST) cover in its January 13, 2026 presentation?

The announcement states RxSight will present at the conference; no specific presentation topics were disclosed.

Will RxSight (RXST) release earnings or guidance during the JP Morgan presentation?

The announcement did not include any earnings, guidance, or financial data.

Where is RxSight headquartered and what does the company do?

RxSight is an ophthalmic medical device company focused on customized vision for patients after cataract surgery.